Intermittent intravenous pamidronate in the treatment of difficult osteoporosis: A review of clinical experience

被引：0
|
作者：
Vasireddy, S
Swinson, DR
Harrison, S
Selby, PL
机构：
[1] Wrightington Hosp, Dept Rheumatol, Wigan, England
[2] Manchester Royal Infirm, Dept Med, Manchester, Lancs, England
来源：
OSTEOPOROSIS INTERNATIONAL | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P91
引用
收藏
页码：S63 / S63
页数：1
相关论文
共 50 条
  • [21] INTERMITTENT PAMIDRONATE THERAPY TO TREATMENT CORTICOSTEROID-INDUCED OSTEOPOROSIS
    Povoroznyuk, Vladyslav
    Orlyk, Tetyana
    Karasevskaya, Tetyana
    BONE, 2010, 46 : S29 - S30
  • [22] INTERMITTENT PAMIDRONATE THERAPY TO TREATMENT CORTICOSTEROID-INDUCED OSTEOPOROSIS
    Povoroznyuk, Vladyslav
    Orlyk, Tetyana
    Karasevskaya, Tetyana
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2010, 39 : 33 - 33
  • [23] Intermittent pamidronate therapy as treatment of corticosteroid-induced osteoporosis
    Povoroznyuk, Vladyslav
    Orlyk, Tetyana
    Karasevskaya, Tetyana
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (05) : 738 - 738
  • [24] Intravenous pamidronate compared with oral alendronate for the treatment of postmenopausal osteoporosis
    Heijckmann, AC
    Juttmann, JR
    Wolffenbuttel, BHR
    NETHERLANDS JOURNAL OF MEDICINE, 2002, 60 (08): : 315 - 319
  • [25] Treatment of osteoporosis with low dose monthly intravenous pamidronate.
    Smith, J
    Shoukri, KC
    Joshi, V
    Taxel, P
    Raisz, LG
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S431 - S431
  • [26] Effect of intravenous pamidronate for treatment of severe osteoporosis in postmenopausal women
    Povoroznyuk, Vladyslav V.
    Bystrytska, Marina A.
    Orlyk, Tatyana V.
    Dzerovych, Natalija I.
    Vayda, Vladymyr M.
    German, Natalija A.
    BONE, 2008, 42 : S82 - S83
  • [27] Primary Prevention of Glucocorticoid-Induced Osteoporosis with Intermittent Intravenous Pamidronate: A Randomized Trial
    Y. Boutsen
    J. Jamart
    W. Esselinckx
    M. Stoffel
    J.-P. Devogelaer
    Calcified Tissue International, 1997, 61 : 266 - 271
  • [28] Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: A randomized trial
    Boutsen, Y
    Jamart, J
    Esselinckx, W
    Stoffel, M
    Devogelaer, JP
    CALCIFIED TISSUE INTERNATIONAL, 1997, 61 (04) : 266 - 271
  • [29] Intravenous intermittent neridronate in the treatment of postmenopausal osteoporosis
    Braga, V
    Gatti, D
    Colapietro, F
    Battaglia, E
    Righetti, D
    Prizzi, R
    Rossini, M
    Adami, S
    BONE, 2003, 33 (03) : 342 - 345
  • [30] Renal tolerability of intermittent intravenous ibandronate treatment for patients with postmenopausal osteoporosis: a review
    Miller, P. D.
    Ward, P.
    Pfister, T.
    Leigh, C.
    Body, J. J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (06) : 1125 - 1133
12345